We are live on
!
Find out more
BIM
Bogle Investment Management Portfolio holdings
AUM
$63M
1-Year Est. Return
51.97%
This Fund
S&P 500
This Quarter
Est. Return
+35.49%
1 Year Est. Return
+51.97%
3 Year Est. Return
+181.13%
5 Year Est. Return
+959%
10 Year Est. Return
–
AUM
$1.39B
AUM Growth
-$56.3M
(-3.9%)
Cap. Flow
-$222M
Cap. Flow
% of AUM
-16.04%
Top 10 Holdings %
Top 10 Hldgs %
12.35%
Holding
543
New
167
Increased
70
Reduced
102
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Myriad Genetics
MYGN
|
+$13.4M |
| 2 |
HOUS
Anywhere Real Estate
HOUS
|
+$13.2M |
| 3 |
JetBlue
JBLU
|
+$12.6M |
| 4 |
GIMO
Gigamon Inc.
GIMO
|
+$12.5M |
| 5 |
Cirrus Logic
CRUS
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRG Energy
NRG
|
+$20M |
| 2 |
Advanced Micro Devices
AMD
|
+$14M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$13.6M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$13.4M |
| 5 |
JOY
Joy Global Inc
JOY
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.43% |
| 2 | Technology | 17.94% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Industrials | 10.51% |
| 5 | Materials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Lexicon Pharmaceuticals
LXRX
$1.03B
| $4.67M | 0.34% |
258,353
+69,928
| +37% | +$1.13M |
|
|
GTLS
102
DELISTED
Chart Industries
GTLS
| $4.66M | 0.34% |
141,831
-9,440
| -6% | -$274K |
|
|
FINL
103
DELISTED
Finish Line
FINL
| $4.62M | 0.33% |
+200,378
| New | +$4.53M |
|
|
NBIS
104
Nebius Group N.V.
NBIS
$48.3B
| $4.53M | 0.33% |
215,003
-412,960
| -66% | -$8.98M |
|
105
Cooper-Standard Automotive
CPS
$523M
| $4.48M | 0.32% |
45,312
-15,532
| -26% | -$1.46M |
|
106
Clearwater Paper
CLW
$339M
| $4.46M | 0.32% |
69,025
+11,153
| +19% | +$705K |
|
|
BZUN
107
Baozun
BZUN
$167M
| $4.38M | 0.32% |
+290,649
| New | +$3.05M |
|
|
AVP
108
DELISTED
Avon Products, Inc.
AVP
| $4.36M | 0.31% |
+770,868
| New | +$3.85M |
|
|
LNW
109
DELISTED
Light & Wonder
LNW
| $4.3M | 0.31% |
381,190
+261,338
| +218% | +$2.56M |
|
110
Supernus Pharmaceuticals
SUPN
$2.59B
| $4.09M | 0.3% |
+165,511
| New | +$3.75M |
|
111
OraSure Technologies
OSUR
$279M
| $4.06M | 0.29% |
509,980
+97,776
| +24% | +$726K |
|
112
Celldex Therapeutics
CLDX
$2.99B
| $4.02M | 0.29% |
66,412
-61,744
| -48% | -$3.85M |
|
|
OME
113
DELISTED
Omega Protein
OME
| $4.01M | 0.29% |
+171,607
| New | +$4.03M |
|
|
DGI
114
DELISTED
DigitalGlobe Inc.
DGI
| $3.97M | 0.29% |
144,540
-140,377
| -49% | -$3.6M |
|
|
RYZ
115
Ryerson Holding Corp
RYZ
$1.44B
| $3.96M | 0.29% |
350,381
+43,861
| +14% | +$593K |
|
116
US Foods
USFD
$22.2B
| $3.89M | 0.28% |
+164,751
| New | +$4M |
|
117
Insteel Industries
IIIN
$593M
| $3.87M | 0.28% |
106,741
+38,737
| +57% | +$1.31M |
|
|
LTRPA
118
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $3.84M | 0.28% |
+175,595
| New | +$3.84M |
|
119
Central Garden & Pet Co
CENT
$2.69B
| $3.83M | 0.28% |
+184,388
| New | +$3.71M |
|
|
VNET
120
VNET Group
VNET
$2.04B
| $3.82M | 0.28% |
+480,774
| New | +$4.44M |
|
121
Usana Health Sciences
USNA
$408M
| $3.73M | 0.27% |
+53,874
| New | +$3.55M |
|
122
Veeva Systems
VEEV
$33.1B
| $3.71M | 0.27% |
+89,776
| New | +$3.48M |
|
123
ANI Pharmaceuticals
ANIP
$1.8B
| $3.7M | 0.27% |
+55,705
| New | +$3.48M |
|
|
CZZ
124
DELISTED
Cosan Limited
CZZ
| $3.69M | 0.27% |
+516,821
| New | +$3.49M |
|
|
CVGW
125
DELISTED
Calavo Growers
CVGW
| $3.68M | 0.27% |
56,240
+31,612
| +128% | +$2.05M |
|
Similar funds
FC
NISOA
UMA
HS
DFG
SRCM
OFM
SAM
Bogle Investment Management's Q3 2016 Portfolio in Review
As of Q3 2016, Bogle Investment Management held 543 positions worth $1.39B, down 3.9% from $1.44B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Bogle Investment Management withdrew a net $222M in Q3 2016, closing 198 positions and reducing 102 holdings. Its most notable exit was NRG Energy, an estimated $20M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bogle Investment Management opened a new position in Myriad Genetics worth $10.9M.
- Bogle Investment Management's largest Q3 2016 buy was Myriad Genetics: 528,969 shares worth $10.9M.
- Bogle Investment Management added most to The Meet Group, Inc. Common Stock in Q3 2016, an estimated $7.93M increase.
- Bogle Investment Management's biggest Q3 2016 reduction was VWR Corporation, cutting an estimated $11.9M.
- Bogle Investment Management fully exited NRG Energy in Q3 2016, selling an estimated $20M.
- Bogle Investment Management's ten largest holdings make up 12% of its $1.39B portfolio in Q3 2016.
- Bogle Investment Management opened 167 new positions and closed 198 in Q3 2016.
- Bogle Investment Management's portfolio value fell 3.9% quarter-over-quarter to $1.39B.
Based on Bogle Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.